Ivabradine is indicated in the management of:
Ivabradine: Bradycardiac drug. It selectively blocks If Na+ channels and reduce HR by inhibiting the hyperpolarization-activated Na+ channel in the SA node. It reduces angina attacks similar to CCBs and b blockers. Advantage of Ivabradine: Lack of effect on GI and bronchial smooth muscle.
Paroxysomal supraventricular tachycardia
Angina pectoris
Cardiomyopathy
Irritable bowel syndrome
CHF, Angina Pectoris and Myocardial Infarction